Literature DB >> 25193465

Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells.

Feng-Hua Wu1, Li-Qiong Luo2, Yi Liu1, Qiu-Xiao Zhan1, Chao Luo2, Jing Luo2, Gui-Mei Zhang2, Zuo-Hua Feng3.   

Abstract

Cyclin D1b, a splice variant of the cell cycle regulator cyclin D1, holds oncogenic functions in human cancer. However, the mechanisms underlying cyclin D1b function remain poorly understood. Here we introduced wild-type cyclin D1a or cyclin D1b variant into non-metastatic MCF-7 cells. Our results show that ectopic expression of cyclin D1b promotes invasiveness of the cancer cells in a cyclin D1a independent manner. Specifically, cyclin D1b is found to modulate the expression of αvβ3, which characterizes the metastatic phenotype, and enhance tumor cell invasive potential in cooperating with HoxD3. Notably, cyclin D1b promotes αvβ3-mediated adhesion and invasive migration, which are associated with invasive potential of breast cancer cells. Further exploration indicates that cyclin D1b makes breast cancer cells more sensitive to toll-like receptor 4 ligand released from damaged tumor cells. These findings reveal a role of cyclin D1b as a possible mediator of αvβ3 transcription to promote tumor metastasis.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cyclin D1b; HoxD3; Invasion; αvβ3-integrin

Mesh:

Substances:

Year:  2014        PMID: 25193465     DOI: 10.1016/j.canlet.2014.08.044

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Cyclin D1b induces changes in the macrophage phenotype resulting in promotion of tumor metastasis.

Authors:  Yuxue Wang; Yi Liu; Lei Xiang; Lintao Han; Xiaowei Yao; Yibing Hu; Fenghua Wu
Journal:  Exp Biol Med (Maywood)       Date:  2021-09-13

2.  Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.

Authors:  Bao-Ping Luo; Jing Luo; Yi-Bing Hu; Xiao-Wei Yao; Feng-Hua Wu
Journal:  Curr Med Sci       Date:  2018-06-22

Review 3.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

4.  ADAR1-mediated regulation of melanoma invasion.

Authors:  Yael Nemlich; Erez Nissim Baruch; Michal Judith Besser; Einav Shoshan; Menashe Bar-Eli; Liat Anafi; Iris Barshack; Jacob Schachter; Rona Ortenberg; Gal Markel
Journal:  Nat Commun       Date:  2018-05-31       Impact factor: 14.919

5.  [99mTc]Tc-Galacto-RGD2 integrin αvβ3-targeted imaging as a surrogate for molecular phenotyping in lung cancer: real-world data.

Authors:  Jingjing Fu; Yan Xie; Tong Fu; Fan Qiu; Fei Yu; Wei Qu; Xiaochen Yao; Aiping Zhang; Zhenhua Yang; Guoqiang Shao; Qingle Meng; Xiumin Shi; Yue Huang; Wei Gu; Feng Wang
Journal:  EJNMMI Res       Date:  2021-06-13       Impact factor: 3.138

6.  Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signaling and malignant features in vitro and in vivo.

Authors:  Marta Sesé; Pedro Fuentes; Anna Esteve-Codina; Eva Béjar; Kimberley McGrail; George Thomas; Trond Aasen; Santiago Ramón Y Cajal
Journal:  Oncotarget       Date:  2017-12-12

7.  Characterization and functional analysis of a slow-cycling subpopulation in colorectal cancer enriched by cell cycle inducer combined chemotherapy.

Authors:  Feng-Hua Wu; Lei Mu; Xiao-Lan Li; Yi-Bing Hu; Hui Liu; Lin-Tao Han; Jian-Ping Gong
Journal:  Oncotarget       Date:  2017-07-26

8.  Exogenous C₈-Ceramide Induces Apoptosis by Overproduction of ROS and the Switch of Superoxide Dismutases SOD1 to SOD2 in Human Lung Cancer Cells.

Authors:  Yuli C Chang; Yao Fong; Eing-Mei Tsai; Ya-Gin Chang; Han Lin Chou; Chang-Yi Wu; Yen-Ni Teng; Ta-Chih Liu; Shyng-Shiou Yuan; Chien-Chih Chiu
Journal:  Int J Mol Sci       Date:  2018-10-02       Impact factor: 5.923

Review 9.  Alternative Splicing and Isoforms: From Mechanisms to Diseases.

Authors:  Qi Liu; Leiming Fang; Chengjun Wu
Journal:  Genes (Basel)       Date:  2022-02-24       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.